Because the ACE2 receptors play a crucial role in the counter‐regulation of blood pressure, the expression of ACE2 within the patient population with cardiovascular diseases, including hypertension, has been hypothesized to be differentially modulated with exposure to certain classes of antihypertensive medication [6, 7]. The gene discussed is ACE2; the disease is hypertensive disorder.